Adrian Blaser

1.6k total citations
30 papers, 1.3k citations indexed

About

Adrian Blaser is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Adrian Blaser has authored 30 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 14 papers in Infectious Diseases and 13 papers in Organic Chemistry. Recurrent topics in Adrian Blaser's work include Tuberculosis Research and Epidemiology (14 papers), Cancer therapeutics and mechanisms (10 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (8 papers). Adrian Blaser is often cited by papers focused on Tuberculosis Research and Epidemiology (14 papers), Cancer therapeutics and mechanisms (10 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (8 papers). Adrian Blaser collaborates with scholars based in New Zealand, United States and Switzerland. Adrian Blaser's co-authors include William A. Denny, Scott G. Franzblau, Brian D. Palmer, Hamish S. Sutherland, Andrew M. Thompson, Zhenkun Ma, Baojie Wan, Iveta Kmentová, Jean‐Louis Reymond and Christopher B. Cooper and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Tetrahedron.

In The Last Decade

Adrian Blaser

30 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Adrian Blaser New Zealand	22	708	599	465	283	112	30	1.3k
Christopher B. Cooper United States	21	684 1.0×	502 0.8×	522 1.1×	287 1.0×	96 0.9×	47	1.3k
Hamish S. Sutherland New Zealand	15	517 0.7×	411 0.7×	423 0.9×	203 0.7×	42 0.4×	29	940
Giulio Cesare Porretta Italy	18	441 0.6×	777 1.3×	490 1.1×	310 1.1×	60 0.5×	29	1.3k
Garrett C. Moraski United States	23	753 1.1×	774 1.3×	597 1.3×	298 1.1×	36 0.3×	35	1.6k
Marion Flipo France	18	501 0.7×	251 0.4×	299 0.6×	158 0.6×	78 0.7×	30	962
Andrew S. Murkin United States	21	650 0.9×	309 0.5×	144 0.3×	174 0.6×	102 0.9×	33	985
Jiyoun Nam South Korea	12	326 0.5×	256 0.4×	202 0.4×	200 0.7×	110 1.0×	19	671
William J. Suling United States	21	743 1.0×	1.1k 1.8×	498 1.1×	298 1.1×	19 0.2×	42	1.8k
Vinayak Singh South Africa	21	559 0.8×	263 0.4×	518 1.1×	250 0.9×	21 0.2×	51	1.1k
Ill Young Lee South Korea	12	392 0.6×	311 0.5×	454 1.0×	323 1.1×	19 0.2×	18	938

Countries citing papers authored by Adrian Blaser

Since Specialization

Citations

This map shows the geographic impact of Adrian Blaser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrian Blaser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrian Blaser more than expected).

Fields of papers citing papers by Adrian Blaser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adrian Blaser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrian Blaser. The network helps show where Adrian Blaser may publish in the future.

Co-authorship network of co-authors of Adrian Blaser

This figure shows the co-authorship network connecting the top 25 collaborators of Adrian Blaser. A scholar is included among the top collaborators of Adrian Blaser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adrian Blaser. Adrian Blaser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Choi, Peter J., Daniel Conole, Hamish S. Sutherland, et al.. (2020). Synthetic Studies to Help Elucidate the Metabolism of the Preclinical Candidate TBAJ-876—A Less Toxic and More Potent Analogue of Bedaquiline. Molecules. 25(6). 1423–1423. 11 indexed citations

Blaser, Adrian, Hamish S. Sutherland, Amy S.T. Tong, et al.. (2019). Structure-activity relationships for unit C pyridyl analogues of the tuberculosis drug bedaquiline. Bioorganic & Medicinal Chemistry. 27(7). 1283–1291. 40 indexed citations

Sutherland, Hamish S., Amy S.T. Tong, Peter J. Choi, et al.. (2019). 3,5-Dialkoxypyridine analogues of bedaquiline are potent antituberculosis agents with minimal inhibition of the hERG channel. Bioorganic & Medicinal Chemistry. 27(7). 1292–1307. 81 indexed citations

Sutherland, Hamish S., Amy S.T. Tong, Peter J. Choi, et al.. (2019). Variations in the C-unit of bedaquiline provides analogues with improved biology and pharmacology. Bioorganic & Medicinal Chemistry. 28(1). 115213–115213. 29 indexed citations

Sutherland, Hamish S., Amy S.T. Tong, Peter J. Choi, et al.. (2018). Structure-activity relationships for analogs of the tuberculosis drug bedaquiline with the naphthalene unit replaced by bicyclic heterocycles. Bioorganic & Medicinal Chemistry. 26(8). 1797–1809. 59 indexed citations

Thompson, Andrew M., P. D. T. O’Connor, Andrew J. Marshall, et al.. (2018). Development of (6R)-2-Nitro-6-[4-(trifluoromethoxy)phenoxy]-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (DNDI-8219): A New Lead for Visceral Leishmaniasis. Journal of Medicinal Chemistry. 61(6). 2329–2352. 33 indexed citations

Choi, Peter J., Hamish S. Sutherland, Amy S.T. Tong, et al.. (2017). Synthesis and evaluation of analogues of the tuberculosis drug bedaquiline containing heterocyclic B-ring units. Bioorganic & Medicinal Chemistry Letters. 27(23). 5190–5196. 48 indexed citations

Thompson, Andrew M., Adrian Blaser, Brian D. Palmer, et al.. (2017). 6-Nitro-2,3-dihydroimidazo[2,1-b][1,3]thiazoles: Facile synthesis and comparative appraisal against tuberculosis and neglected tropical diseases. Bioorganic & Medicinal Chemistry Letters. 27(11). 2583–2589. 24 indexed citations

Tong, Amy S.T., Peter J. Choi, Adrian Blaser, et al.. (2017). 6-Cyano Analogues of Bedaquiline as Less Lipophilic and Potentially Safer Diarylquinolines for Tuberculosis. ACS Medicinal Chemistry Letters. 8(10). 1019–1024. 60 indexed citations

10.

Thompson, Andrew M., Adrian Blaser, Brian D. Palmer, et al.. (2015). Biarylmethoxy 2-nitroimidazooxazine antituberculosis agents: Effects of proximal ring substitution and linker reversal on metabolism and efficacy. Bioorganic & Medicinal Chemistry Letters. 25(18). 3804–3809. 11 indexed citations

11.

Thompson, Andrew M., Hamish S. Sutherland, Brian D. Palmer, et al.. (2011). Synthesis and Structure–Activity Relationships of Varied Ether Linker Analogues of the Antitubercular Drug (6S)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824). Journal of Medicinal Chemistry. 54(19). 6563–6585. 99 indexed citations

12.

Kmentová, Iveta, Hamish S. Sutherland, Brian D. Palmer, et al.. (2010). Synthesis and Structure−Activity Relationships of Aza- and Diazabiphenyl Analogues of the Antitubercular Drug (6S)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824). Journal of Medicinal Chemistry. 53(23). 8421–8439. 68 indexed citations

13.

Thompson, Andrew M., Adrian Blaser, Robert F. Anderson, et al.. (2008). Synthesis, Reduction Potentials, and Antitubercular Activity of Ring A/B Analogues of the Bioreductive Drug (6S)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824). Journal of Medicinal Chemistry. 52(3). 637–645. 82 indexed citations

14.

Murphy, Sean T., Edmund L. Ellsworth, Susan E. Hagen, et al.. (2007). The synthesis and biological evaluation of novel series of nitrile-containing fluoroquinolones as antibacterial agents. Bioorganic & Medicinal Chemistry Letters. 17(8). 2150–2155. 79 indexed citations

15.

Hay, Michael P., Kevin O. Hicks, Frederik B. Pruijn, et al.. (2006). 258 POSTER Tricyclic triazin 1,4-dioxides: a new class of hypoxia-selective cytotoxins with improved extravascular transport compared to tirapazamine. European Journal of Cancer Supplements. 4(12). 82–83. 1 indexed citations

16.

Hauser, Jürg, et al.. (2004). (1SR,2SR,4SR)-7-Oxabicyclo[2.2.1]hept-5-ene-2-carboxylic acid. Acta Crystallographica Section E Structure Reports Online. 60(3). o381–o382. 1 indexed citations

17.

Blaser, Adrian & Jean‐Louis Reymond. (2000). ChemInform Abstract: Stereoselective Inhibition of α‐L‐Fucosidases by N‐Benzyl Aminocyclopentitols.. ChemInform. 31(38). 1 indexed citations

18.

Blaser, Adrian & Jean‐Louis Reymond. (1999). A Selectiveα-L-Fucosidase Inhibitor Based on an Aminocyclopentane Framework. Helvetica Chimica Acta. 82(5). 760–768. 21 indexed citations

19.

Boss, Olivier, et al.. (1999). Synthesis and Evaluation of Aminocyclopentitol Inhibitors of β-Glucosidases. Organic Letters. 2(2). 151–154. 30 indexed citations

20.

Hildbrand, Stefan, et al.. (1997). 5-Substituted 2-Aminopyridine C-Nucleosides as Protonated Cytidine Equivalents: Increasing Efficiency and Selectivity in DNA Triple-Helix Formation. Journal of the American Chemical Society. 119(24). 5499–5511. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact